Symptoms and their implications on quality of life and psychological distress in sarcoma patients.


Journal

Future oncology (London, England)
ISSN: 1744-8301
Titre abrégé: Future Oncol
Pays: England
ID NLM: 101256629

Informations de publication

Date de publication:
Mar 2021
Historique:
pubmed: 30 1 2021
medline: 2 10 2021
entrez: 29 1 2021
Statut: ppublish

Résumé

The aim of this study was to investigate symptoms, their variation over time and their relationship with quality of life (QoL)/psychological distress in sarcoma patients, as few data regarding QoL and psychological distress in this set of patients are currently available. A total of 188 sarcoma patients from an Italian referral center were involved. Symptoms and financial difficulties were evaluated with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire from the first treatment and over the follow-up period, up to 6 years. The authors found that patients with sarcoma experience several symptoms, especially fatigue and pain, which may dramatically worsen QoL and psychological distress. In conclusion, patients with sarcoma often experience fatigue, pain and financial difficulties, which negatively impacts QoL and psychological distress. To ameliorate overall QoL, proper control of symptoms is necessary.

Identifiants

pubmed: 33508959
doi: 10.2217/fon-2020-0572
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

817-823

Auteurs

Gabriella Maggi (G)

Psychology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Irene Terrenato (I)

Biostatistic Unit - Scientific Direction, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Luca Giacomelli (L)

Polistudium SRL, Milan, Italy.
Department of Surgical Sciences & Integrated Diagnostics, University of Genoa, Genoa, Italy.

Viviana Bifano (V)

Psychology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Alessandra Gravili (A)

Psychology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Wioletta Faltyn (W)

Sarcoma Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Virginia Ferraresi (V)

First Division of Medical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Leonardo Favale (L)

Orthopaedics Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Maria Grazia Petrongari (MG)

Deptartment of Radiation Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Nicola Salducca (N)

Orthopaedics Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Sabrina Vari (S)

First Division of Medical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Chiara Falcicchio (C)

Psychology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Barbara Rossi (B)

Orthopaedics Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Roberto Biagini (R)

Orthopaedics Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Patrizia Pugliese (P)

Psychology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH